These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1499 related articles for article (PubMed ID: 32103760)

  • 41. CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1-CXCR2 induced NETs.
    Xiong G; Chen Z; Liu Q; Peng F; Zhang C; Cheng M; Ling R; Chen S; Liang Y; Chen D; Zhou Q
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CCL2/CCR2 Axis Promotes the Progression of Salivary Adenoid Cystic Carcinoma via Recruiting and Reprogramming the Tumor-Associated Macrophages.
    Yang Z; Li H; Wang W; Zhang J; Jia S; Wang J; Wei J; Lei D; Hu K; Yang X
    Front Oncol; 2019; 9():231. PubMed ID: 31024838
    [No Abstract]   [Full Text] [Related]  

  • 43. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
    Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
    Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
    Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
    Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.
    Cortés M; Sanchez-Moral L; de Barrios O; Fernández-Aceñero MJ; Martínez-Campanario MC; Esteve-Codina A; Darling DS; Győrffy B; Lawrence T; Dean DC; Postigo A
    EMBO J; 2017 Nov; 36(22):3336-3355. PubMed ID: 29038174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.
    Zhao F; Tian H; Wang Y; Zhang J; Liu F; Fu L
    Cancer Immunol Immunother; 2023 Jun; 72(6):1835-1851. PubMed ID: 36688997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventive Treatment with PD-1 Antibody Increases Tissue-resident Memory T Cells Infiltration and Delays Esophageal Carcinogenesis.
    Xiao Z; Yan R; Liu H; Huang X; Liang Z; An G; Ge Y
    Cancer Prev Res (Phila); 2023 Dec; 16(12):669-679. PubMed ID: 37857481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
    Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
    J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Liu M; Li F; Liu B; Jian Y; Zhang D; Zhou H; Wang Y; Xu Z
    BMC Med Genomics; 2021 Mar; 14(1):75. PubMed ID: 33691689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-Derived C-C Motif Ligand 2 Induces the Recruitment and Polarization of Tumor-Associated Macrophages and Increases the Metastatic Potential of Bladder Cancer Cells in the Postirradiated Microenvironment.
    Chiang Y; Tsai YC; Wang CC; Hsueh FJ; Huang CY; Chung SD; Chen CH; Pu YS; Cheng JC
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):321-333. PubMed ID: 35691449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infiltrated M2 tumour-associated macrophages in the stroma promote metastasis and poor survival in oesophageal squamous cell carcinoma.
    Zhou J; Zheng S; Liu T; Liu Q; Chen Y; Ma R; Tan D; Lu X
    Histol Histopathol; 2019 May; 34(5):563-572. PubMed ID: 30417922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis.
    Dong Y; Dong Y; Zhu C; Yang L; Wang H; Li J; Zheng Z; Zhao H; Xie W; Chen M; Jie Z; Li J; Zang Y; Shi J
    Cell Commun Signal; 2024 Jul; 22(1):364. PubMed ID: 39014433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population.
    Rong L; Liu Y; Hui Z; Zhao Z; Zhang Y; Wang B; Yuan Y; Li W; Guo L; Ying J; Song Y; Wang L; Zhou Z; Xue L; Lu N
    Diagn Pathol; 2019 Jan; 14(1):6. PubMed ID: 30684971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
    Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
    Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
    Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
    Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
    Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
    Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.